HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Tacks Organic Personal-Care Amendment To 2010 FDA Funding Bill

This article was originally published in The Rose Sheet

Executive Summary

The fiscal 2010 Agriculture spending bill that passed the Senate Aug. 4 includes an amendment that could signal government movement to bring order to the organic personal-care marketplace

You may also be interested in...



Newcomers To White House, FDA Augur Up-Regulation: Top Stories Of 2009

The prospect of heightened regulation under the Obama administration and a reorganized FDA - in an environment characterized by high pressure from public safety groups - commanded the attention of personal-care interests in 2009

Newcomers To White House, FDA Augur Up-Regulation: Top Stories Of 2009

The prospect of heightened regulation under the Obama administration and a reorganized FDA - in an environment characterized by high pressure from public safety groups - commanded the attention of personal-care interests in 2009

Terressentials Organic "Extremists" Maintain USDA Seal Is "Real Deal"

Terressentials will continue working to clear marketplace confusion and raise consumer awareness in accordance with its uncompromising stance on "real organic," company co-founder Diana Kaye indicated July 28

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016338

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel